FibroBiologics, Inc.(NasdaqCM: FBLG) dropped from Russell 3000 Index - MarketScreener
10 hours ago • Google News
FibroBiologics, Inc. Common Stock (FBLG)
US$ 0.95-6.86%
Price Chart
Key Statistics
Market Cap
$ 24.26M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
72.1K
52W High
$ 5.62
52W Low
$ 0.62
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
0.9113
200-Day MA
1.8025
52 Week High
5.62
52 Week Low
0.618
About FBLG
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company.
Employees
13
Headquarters
Houston, TX
CEO
Mr. Peter O'Heeron
Latest News
FibroBiologics Taps Former Virax IPO Leader as CFO Ahead of Critical Clinical Trials - Stock Titan
4 weeks ago • Google News
FBLG Stock Price and Chart — NASDAQ:FBLG - TradingView
2025-02-08 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg